Klobuchar Wants To Stop ‘Pay-For-Delay’ Deals That Keep Drug Prices High

[khn_slabs slabs="943135" view="inline"] Washington’s recent fixation with lowering drug costs has introduced Americans to once-insider terms like “pharmacy benefit managers” and “list prices.” [partner-box]During an April 22 CNN town hall event for Democratic candidates, Sen. Amy Klobuchar (D-Minn.) described a drugmaker practice that sounds a lot like bribery — drawing attention to yet another secretive process that lawmakers and experts say prevents patients from obtaining affordable prescription drugs. America, meet “pay-for-delay.” “We can stop this horrible practice where big pharmaceuticals pay off, they literally pay off generics t...

Read the full post at Syndicate – Kaiser Health News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive